环氧化酶2基因多态性与大动脉粥样硬化型脑梗死患者预后的相关研究

被引:7
作者
曹立平 [1 ,2 ]
张治中 [1 ,2 ]
张雨蒙 [1 ,2 ]
白文 [1 ,2 ]
孙文珊 [1 ,2 ]
李松 [1 ,2 ]
段作伟 [1 ,2 ]
刘新峰 [1 ,2 ]
徐格林 [1 ,2 ]
机构
[1] 南方医科大学南京临床学院
[2] 南京军区南京总医院神经内科
关键词
脑梗死; 环氧化酶2; 基因型; 动脉粥样硬化; 阿司匹林; 基因频率; 预后;
D O I
暂无
中图分类号
R743.33 [脑栓塞];
学科分类号
1002 ;
摘要
目的探讨环氧化酶2(COX-2)基因rs20417和rs5275 2个位点多态性与服用阿司匹林治疗的大动脉粥样硬化型脑梗死患者临床预后的相关性。方法入选南京卒中注册系统中2009年12月2012年10月确诊为大动脉粥样硬化型脑梗死、并长期服用阿司匹林的患者962例。应用改进的多重连接酶检测反应技术分析COX-2基因2个位点的基因型。平均随访(15.13±7.42)个月,记录主要终点事件。结果 rs20417和rs5275最小等位基因频率分别为5.1%、19.1%。随访期间,有89例(9.25%)发生主要终点事件。rs20417位点CC+CG型与GG型主要终点事件发生率比较,差异无统计学意义(HR=0.92,95%CI:0.44~1.89,P=0.81)。rs5275位点AA型与AG+GG型主要终点事件发生率比较,差异无统计学意义(HR=1.17,95%CI:0.76~1.79,P=0.48)。多因素Cox风险比例模型分析,男性患者预后较好,rs20417C等位基因和rs5275G等位基因携带者与预后不相关(P>0.05)。结论 COX-2基因rs20417和rs5275位点多态性可能与大动脉粥样硬化型脑梗死患者临床预后无关。
引用
收藏
页码:50 / 53
页数:4
相关论文
共 18 条
[1]  
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials[J] . Antithrombotic Trialists’ (ATT) Collaboration. &nbspThe Lancet . 2009 (9678)
[2]  
Platelet response to aspirin in Chi-nese stroke patients is independet of genetic polymorphisms ofCOX-1C50T and COX-2 G765C. Yi X,Zhou Q,Lin J,et al. J Atheroscler Thrombo . 2013
[3]  
Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Timothy Goodman,Albert Ferro,Pankaj Sharma. British Journal of Clinical Pharmacology . 2008
[4]  
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. George Krasopoulos,Stephanie J Brister,W Scott Beattie,Michael R Buchan. British Medical Journal . 2008
[5]   Aspirin resistance [J].
Hankey, GJ ;
Eikelboom, J .
LANCET, 2006, 367 (9510) :606-617
[6]  
Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms[J] . Shinichi Takahashi,Miho Ushida,Risa Komine,Aya Shimodaira,Toshihiro Uchida,Hiroaki Ishihara,Toshiro Shibano,Gentaro Watanabe,Yasuo Ikeda,Mitsuru Murata. &nbspThrombosis Research . 2007 (4)
[7]  
Sex Differences in Stroke Recovery and Stroke-Specific Quality of Life: Results From a Statewide Stroke Registry[J] . Julia Warner Gargano,Mathew J. Reeves. &nbspStroke . 2007 (9)
[8]  
Aspirin resistance: Effect of clinical, biochemical and genetic factors[J] . Richard FitzGerald,Munir Pirmohamed. &nbspPharmacology and Therapeutics . 2011 (2)
[9]  
Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 Polymorphisms on 90-Day Ischemic Stroke Functional Outcome: A Novel Finding[J] . Jane Maguire,Ammarin Thakkinstian,Christopher Levi,Lisa Lincz,Linda Bisset,Jonathan Sturm,Rodney Scott,Scott Whyte,John Attia. &nbspJournal of Stroke and Cerebrovascular Diseases . 2011 (2)
[10]   Association of COX-2 rs20417 with aspirin resistance [J].
Sharma, Vandana ;
Kaul, Subhash ;
Al-Hazzani, Amal ;
Alshatwi, Ali A. ;
Jyothy, A. ;
Munshi, Anjana .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (01) :95-99